Drug Shortage: Horizant

Elizabeth Davis
Posted on

The manufacturers of restless leg syndrome and postherpetic neuralgia treatment Horizant (extended-release gabapentin) have made an announcement that the 600 mg tablet is temporarily backordered.

XenoPort, a biopharmaceutical company, originally developed the drug, and GlaxoSmithKline has been responsible for manufacturing and commercialization (advertising and distributing) of Horizant until April 30, 2013.

There’s a manufacturing delay surrounding the May 1, 2013 handoff, and it will take some time to get Horizant back into pharmacies. The current estimate for Horizant to be fully available again? Not until June 2013.

For more information before May 1, call GlaxoSmithKline at 1-888-825-5249

For more information on May 1 and after, contact XenoPort at 1-877-XENOPRT (1-877-936-6778)

The Horizant website is currently only showing the prescribing information, but there may also be more info there at a later date: http://www.horizant.com/index.html

Update: As of 5/24/2013, XenoPort has notified the FDA that the Horizant 600 mg tablet is available. It may take some time for pharmacies to restock, so the June 2013 availability date is still likely an accurate estimate.

Drugs featured in this story

Filed under